| Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data CG Parsons, W Danysz, G Quack Neuropharmacology 38 (6), 735-767, 1999 | 1222 | 1999 |
| Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications W Danysz, CG Parsons Pharmacological reviews 50 (4), 597-664, 1998 | 876 | 1998 |
| Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse CG Parsons, A Stöffler, W Danysz Neuropharmacology 53 (6), 699-723, 2007 | 842 | 2007 |
| Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine–searching for the connections W Danysz, CG Parsons British journal of pharmacology 167 (2), 324-352, 2012 | 657 | 2012 |
| Glutamate in CNS disorders as a target for drug development: an update. CG Parsons, W Danysz, G Quack Drug news & perspectives 11 (9), 523-569, 1998 | 560 | 1998 |
| The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence W Danysz, CG Parsons International journal of geriatric psychiatry 18 (S1), S23-S32, 2003 | 527 | 2003 |
| Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease—a unified glutamatergic hypothesis on the mechanism of action W Danysz, CG Parsons, HJÖ MÖbius, A StÖffler, GÜ Quack Neurotoxicity research 2 (2), 85-97, 2000 | 457 | 2000 |
| Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents—preclinical studies W Danysz, CG Parsons, J Kornhuber, WJ Schmidt, G Quack Neuroscience & Biobehavioral Reviews 21 (4), 455-468, 1997 | 442 | 1997 |
| Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease CG Parsons, W Danysz, A Dekundy, I Pulte Neurotoxicity research 24, 358-369, 2013 | 378 | 2013 |
| Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo CG Parsons, G Quack, I Bresink, L Baran, E Przegalinski, W Kostowski, ... Neuropharmacology 34 (10), 1239-1258, 1995 | 373 | 1995 |
| Learning impairment in rats by N-methyl-D-aspartate receptor antagonists W Danysz, JT Wroblewski, E Costa Neuropharmacology 27 (6), 653-656, 1988 | 278 | 1988 |
| Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model A Dekundy, M Lundblad, W Danysz, MA Cenci Behavioural brain research 179 (1), 76-89, 2007 | 269 | 2007 |
| Modulation of learning processes by ionotropic glutamate receptor ligands W Danysz, W Zajaczkowski, CG Parsons Behavioural pharmacology 6 (5), 455-474, 1995 | 247 | 1995 |
| Modulation of glutamate receptors: molecular mechanisms and functional implications JT Wroblewski, W Danysz Annual Review of Pharmacology and Toxicology 29 (1), 441-474, 1989 | 247 | 1989 |
| Antagonism of metabotropic glutamate receptor type 5 attenuates l‐DOPA‐induced dyskinesia and its molecular and neurochemical correlates in a rat model of … F Mela, M Marti, A Dekundy, W Danysz, M Morari, MA Cenci Journal of neurochemistry 101 (2), 483-497, 2007 | 237 | 2007 |
| Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization CG Parsons, W Danysz, G Quack, S Hartmann, B Lorenz, C Wollenburg, ... Journal of Pharmacology and Experimental Therapeutics 283 (3), 1264-1275, 1997 | 232 | 1997 |
| Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats Z Rogóż, G Skuza, J Maj, W Danysz Neuropharmacology 42 (8), 1024-1030, 2002 | 229 | 2002 |
| Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov European neuropsychopharmacology 17 (3), 172-179, 2007 | 225 | 2007 |
| Pharmacodynamics of memantine: an update CG Parsons, G Rammes, W Danysz Current neuropharmacology 6 (1), 55-78, 2008 | 216 | 2008 |
| Glutamate antagonists have different effects on spontaneous locomotor activity in rats W Danysz, U Essmann, I Bresink, R Wilk Pharmacology Biochemistry and Behavior 48 (1), 111-118, 1994 | 216 | 1994 |
Adam PlaznikInstytut Psychiatrii i NeurologiiVerified email at ipin.edu.pl
